Kai Michaelis,1,
Karin Lindner,1
Paolo Landini,3
Jörg Hacker,1
Jean-Marc Ghigo,2 and
Ulrich Dobrindt1*
Institut für Molekulare Infektionsbiologie, Bayerische Julius-Maximilians-Universität Würzburg, Röntgenring 11, 97070 Würzburg, Germany,1 Groupe de Génétique des Biofilms, Institut Pasteur, URA CNRS 2172, 25 rue du Docteur Roux, 75724 Paris Cedex 15, France,2 Swiss Federal Institute of Environmental Technology (EAWAG), Überlandstrasse 133, 8600 Dübendorf, Switzerland3
Received 27 May 2005/ Accepted 23 November 2005
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Escherichia coli biofilms are frequently described for catheter-associated or chronic urinary tract infections (UTIs), one of the most common bacterial diseases (16, 28). Uropathogenic E. coli (UPEC) accounts for about 80% of all acute community-acquired UTI cases and a high proportion of nosocomial UTIs (33, 60, 76). The ability of E. coli to form a biofilm may contribute to the colonization of catheter surfaces, which could protect the bacteria from the mechanical flow of urine, host defenses, and antibiotics. UPEC biofilm formation may also be involved in chronic and recurring UTIs, since it has recently been shown that some UPEC strains can form intracellular biofilm-like structures that serve as a reservoir that can be the source of recurrent infections (2, 51). Nevertheless, little is known about the persistence of UPEC in the urinary tract and the establishment of chronic and recurring UTIs. Consequently, a better understanding of the mechanisms involved in E. coli biofilm formation, as well as the relationship between pathogenesis and biofilm formation, is needed.
Among the factors known to contribute to the formation of biofilms by E. coli are flagella, various classes of fimbriae, curli, antigen 43 (Ag43), and the extracellular matrix compounds colanic acid, cellulose, and poly-ß-1,6-N-acetyl-D-glucosamine (19, 20, 22, 28, 94, 96). Regulation of gene expression during the different steps of E. coli biofilm formation is complex and not well understood. Surface attachment and microcolony formation seem to respond to signals arising from surface contact and osmolarity sensed via the CpxA/CpxR (6, 29, 49, 66) and EnvZ/OmpR (68, 75) two-component signaling pathways, respectively. The availability of nutrients and other stress signals also play an important role in E. coli biofilm formation. For example, catabolite repression (46, 47) and the alternative sigma factor RpoS (1, 15) have been shown to affect biofilm maturation, as do the regulators H-NS, YaiC, and RcsC (10, 32, 57). Another level of biofilm regulation is exemplified by expression of cell surface-associated structures which undergo phase variation, i.e., the reversible periodic switch between an "ON" phase and an "OFF" phase of gene expression that results in variation of the level of expression in individual cells of a population. Phase variation results from the interplay of different regulatory factors (37, 89, 91, 92).
In this study, the effects of different global regulators and of pathogenicity island I536 (PAI I536)- and PAI II536-encoded factors on the formation of biofilms by UPEC strain 536 were analyzed. The RfaH protein, a transcriptional antiterminator, was identified as a repressor of biofilm formation in E. coli. According to the current model of action, RfaH recognizes an 8-bp DNA motif upstream of RfaH-dependent genes, the ops element, where it can be recruited by the transcription elongation complex. This complex is then able to read through terminator structures within polycistronic operons, thus preventing operon polarity (3, 5). RfaH-affected operons include the operons coding for lipopolysaccharide (LPS) biosynthesis (17), the F factor (79), different capsules (14, 70, 85), hemin uptake receptor (64), and the toxins alpha-hemolysin and cytotoxic necrotizing factor 1 (58, 59). The mechanism underlying biofilm formation in rfaH mutants of uropathogenic E. coli strain 536 and nonpathogenic E. coli K-12 strain MG1655 was then investigated.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
Determination of physicochemical properties of bacterial strains. The electrophoretic mobility, a function of the overall surface charge of the bacterial cells, was determined by the method of van Loosdrecht and coworkers (90), using a Doppler electrophoretic light-scattering analyzer (Zeta-Master; Malvern Instruments Ltd., United Kingdom). For measurement, cells grown overnight in M9 glucose medium at 37°C were harvested, washed, and resuspended in PBS (pH 7.0) at a concentration of ca. 5 x 106 CFU/ml. The same suspensions were used to determine bacterial cell hydrophobicity, using the contact angle measurement method described by Jucker et al. (50).
Biofilm formation assay. Comparisons of biofilm development in microfermentors were performed at least in triplicate as described previously (6, 34). Briefly, overnight cultures were grown in M63B1 medium containing 0.4% glucose at 37°C. Inoculation was performed by dipping the microfermentor removable spatula in a culture containing 108 bacteria/ml for 1 min, followed by rapid rinsing into M63B1 medium; then the spatula was reintroduced into the microfermentor. The medium was pumped through the microfermentors at a constant rate (0.75 ml/min). Images of the biofilm formed on the internal Pyrex spatula were captured after 24 h to 48 h of growth, and the organisms were resuspended in 10 ml of M63B1 minimal medium. The OD600 of each resulting suspension was then determined. This optical density directly reflected the biomass on the spatula.
Microscopy and image analysis. Biofilm development was recorded with a Nikon Coolpix 950 digital camera. Scanning laser electronic microscopy was performed with biofilms grown in microfermentors on Thermanox slides (Nalgene) fixed on internal removable glass slides as described by Prigent-Combaret et al. (69) at the Laboratoire de Biologie Cellulaire et Microscopie Electronique, UFR Médecine, Tours, France.
Autoaggregation assays. Autoaggregation assays were performed as described by Roux et al. (77). Cells were grown in LB medium at 37°C for 8 h. Cultures were diluted 1:100 in M63B1 medium containing 0.4% glucose and grown overnight at 37°C (16 to 18 h). The culture OD600 was adjusted to 3 by dilution with M63B1 medium, and 3-ml portions of each culture were transferred to 5-ml tubes. The tubes were incubated without agitation at room temperature. The OD600 of the upper part of the culture in each standing tube was determined every hour for 6 h and after 24 h before images were captured.
Detection of flu expression in E. coli K-12 strains MG1655 and 536 by immunoblot analysis. Overnight cultures were harvested by centrifugation and washed in 0.9% (wt/vol) NaCl, and the concentrations were standardized to a final OD600 of 1.0 in 75 mM NaCl-0.5 mM Tris (pH 7.4). The passenger domain of Ag43 variants was released from the surface of the cells by heating at 60°C for 20 min. The cells were immediately removed by centrifugation, and the resultant protein in the supernatant was precipitated overnight at 4°C with 10% (vol/vol) trichloroacetic acid. The pellet was dried and resuspended in Tris-EDTA buffer. After the protein concentrations of the samples were adjusted, sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis buffer was added (56) and the samples were boiled for 3 min prior to gel electrophoresis. Separation of the protein samples and detection of the Ag43 passenger domains were carried out as described previously (27). A polyclonal serum raised against the Ag43 passenger domain of strain MG1655 (P. Owen, Dublin, Ireland) was used as the primary serum, and the secondary antibody was horseradish peroxidase-conjugated anti-rabbit immunoglobulin (DAKO, Hamburg, Germany). Chemiluminescence was detected using a Chemi Lux imager (Intas Science Imaging Instruments GmbH, Göttingen, Germany).
Analysis of long-chain LPS expression in E. coli K-12 strains MG1655 and 536 and derivatives of these strains. LPS was isolated from the E. coli strains used in this study as previously described (36).
DNA techniques.
QIAGEN (Hilden, Germany) products were used to isolate plasmid DNA and to purify DNA fragments or PCR products. For cloning experiments, the Dap Goldstar DNA polymerase (Eurogentec, Seraing, Belgium) was used. Primers were obtained from Sigma-GENOSYS (Taufkirchen, Germany), while restriction enzymes were purchased from New England Biolabs (Frankfurt am Main, Germany). For Southern blot hybridization, DNA was transferred to Nytran Supercharge nylon membranes (Schleicher & Schuell BioSciences, Dassel, Germany). Hybridization with and detection of horseradish peroxidase-labeled probes were performed with the ECL labeling and signal detection system (Amersham Biosciences, Freiburg, Germany). Gene inactivation was carried out by allelic exchange using the suicide vector pCVD442 as described previously (61, 62) or by using lambda Red-mediated recombination of linear DNA fragments as previously described (11, 21, 24). The complete list of primers used for gene inactivation is available on the homepage of the "Enterobacteria" research group of the Institute for Molecular Biology of Infectious Diseases (http://www.uni-wuerzburg.de/infektionsbiologie/imi-start.htm). rfaH, ORF52III, and ORF47V were disrupted by an antibiotic cassette flanked by specific FLP recombinase sites (frt). After interruption of the genes, the antibiotic cassette was subsequently removed by use of plasmid pCP20 expressing the FLP flipase (12). Complementation of strain 536rfaH was achieved by chromosomal insertion of the rfaH gene into the
attB site as described previously (25). For this purpose, a 927-bp DNA fragment that included rfaH together with its flanking up- and downstream regions was amplified by PCR from strain 536 and cloned (BamHI/EcoRI) into pLDR10. The NotI fragment of the resulting plasmid, including the bla and rfaH genes as well as the
attP site, was religated and used for chromosomal insertion into
attB of strain 536rfaH with use of helper plasmid pLDR8. All of the rpoS gene and all of the luxS gene, except their start and stop codons, were completely deleted by allelic exchange using pCVD442-based constructs. hha and evgA were inactivated by insertion of cat and a neo cassette, respectively, via allelic exchange using pCVD442-based constructs. The different constructions were verified by PCR and/or Southern blot hybridization.
RNA techniques. A small quantity of total RNA was isolated from E. coli using an RNeasy purification kit (QIAGEN). Large quantities of total RNA were extracted from 25-ml portions of bacterial cultures which were immediately mixed with 10 g of crushed ice precooled to 80°C and harvested by centrifugation at 4°C. The cells were resuspended in 0.6 ml of an ice-cold buffer containing 10 mM KCl, 5 mM MgCl2, and 10 mM Tris (pH 7.4) and then immediately added to 0.6 ml of hot lysis buffer (0.4 M NaCl, 40 ml EDTA, 1% sodium dodecyl sulfate) containing 1% ß-mercaptoethanol and 200 µl of water-saturated phenol. The mixture was incubated at 90°C for 2 min (13). Cell debris was removed by centrifugation for 10 min at room temperature, and the supernatant was then extracted two or three times with phenol and one or two times with chloroform, precipitated with LiCl overnight, pelleted, washed, and dried. The dried RNA pellet was dissolved in 100 µl sterile diethyl pyrocarbonate-treated water. To obtain DNA-free RNA, the raw RNA was subjected twice to 20 min of DNase treatment (0.5 U/µl of RNase-free DNase I [Roche Diagnostics]), followed by LiCl precipitation.
Genome-wide transcriptional analysis using DNA macroarrays.
According to the results of the initial adhesion tests, the factor(s) involved in increased adherence was expressed in the exponential growth phase. In order to assess differences in the transcription profiles of exponentially growing planktonic cells (M63 medium, 37°C) of wild-type strain 536 and the isogenic rfaH mutant, E. coli K-12 strain MG1655-specific DNA arrays (Panorama E. coli gene arrays; Sigma-Genosys, Cambridge, United Kingdom) were used in combination with the so called E. coli "pathoarray" carrying an assortment of probes specific for many of the known pathogenicity island- or virulence-associated genes of uropathogenic E. coli strain 536, as well as other extraintestinal pathogenic and intestinal pathogenic E. coli strains (26). For each strain, four different RNA preparations from independent cultures were used for cDNA synthesis as follows. DNA-free total RNA was reverse transcribed and radioactively labeled. In short, 30 µg of total RNA was used as the template for cDNA synthesis in a reaction mixture containing 4.8 µg of random hexanucleotide primers (QIAGEN, Hilden, Germany), 30 µCi [
-33P]dATP (1,000 to 3,000 Ci/mmol), 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl2, 10 mM dithiothreitol, 0.5 mM dGTP, 0.5 mM dCTP, 0.5 mM dTTP, 20 U RNase inhibitor (Roche, Mannheim, Germany), and 10 U Omniscript reverse transcriptase (QIAGEN, Hilden, Germany). After incubation for 3 h at 37°C, unincorporated nucleotides were removed with Microspin G 50 spin columns (Amersham Pharmacia) prior to denaturation for 10 min at 90°C. Before hybridization, the DNA macroarrays were rinsed in 2x SSPE and subsequently prehybridized for 3 h at 65°C in 5 ml hybridization solution (5x SSPE, 2% SDS, 1x Denhardt's solution, 100 µg/ml sheared, denatured herring sperm DNA) (1x SSPE is 0.18 M NaCl, 10 mN NaH2PO4, and 1 mM EDTA [pH 7.7]). After addition of the probe denatured in 3 ml of hybridization solution, the arrays were incubated for 12 to 18 h at 65°C. After hybridization, the blots were washed twice with wash solution (0.5x SSPE, 0.2% SDS) for 2 to 3 min at room temperature, followed by three wash steps for 10 min at 65°C. Washed filters were air dried and exposed for 1 or 2 days to a phosphorimager screen (superresolution type) prior to scanning with a Typhoon 8600 variable-mode imager (Molecular Dynamics).
The Panorama E. coli K-12 strain MG1655-specific gene array and the "E. coli Pathoarray" were hybridized in four different experiments using independently generated cDNA probes. The scanned arrays were analyzed with the ArrayVision software (Imaging Research, St. Catharines, Canada), followed by visual inspection. Normalized intensity values for the individual spots were calculated by using the overall-spot-normalization function of ArrayVision. Background values were measured in the four corners of every spot. For identification of genes with statistically significant changes in expression, SAM, a statistical technique for finding significant genes in a set of array experiments, was used (88) (http://www-stat.stanford.edu/
tibs/SAM/). Genes with statistically significant changes in expression were identified by assimilating a set of gene-specific t tests. Each gene was assigned a score based on its change in expression relative to the standard deviation of repeated measurements for the gene. Genes whose scores exceeded a certain threshold were considered potentially significant. The percentage of such genes identified by chance was the false discovery rate (FDR). The delta value chosen (which corresponded to the FDR) was <10%. The FDR was calculated by determining the ratio of the estimated number of "false significant" genes to the total number of "significant" genes. Genes that were significant according to this analysis and with mRNA levels that were changed at least twofold were considered.
Comparative analysis of flu transcription levels in E. coli wild-type strains and corresponding rfaH mutants by semiquantitative RT-PCR and discrimination of flu orthologs of E. coli strain 536. For reverse transcription PCR (RT-PCR), 3 µg DNA-free RNA was mixed with 0.5 µg random hexamer primers (QIAGEN, Hilden, Germany) and heated for 10 min at 70°C. After incubation on ice for 5 min, cDNA synthesis was performed with Omniscript reverse transcriptase (QIAGEN, Hilden, Germany) at 37°C. After 3 h of incubation aliquots of the reverse-transcribed RNA were used as cDNA templates for PCRs.
Amplification was performed with Taq polymerase (QIAGEN, Hilden, Germany) under the following conditions: 25 s of denaturation at 92°C, 45 s of annealing at 57°C, 130 s of elongation at 72°C. The primers used for amplification are available in the supplemental material at http://www.uni-wuerzburg.de/infektionsbiologie/imi-start.htm and at http://www.uni-wuerzburg.de/infektionsbiologie/imi-start.htm. To discriminate the transcript levels of the two flu orthologs located on PAI III536 and PAI V536, a 590-bp region of flu was reverse transcribed (primer KM-Ag43_RT) and amplified with primers KM-Ag43_fwd and KM-Ag43_rev, which allowed reverse transcription and amplification of a conserved region of both flu transcript variants. The resulting 590-bp RT-PCR product consisted of a mixture of the two flu ortholog transcripts, which could be distinguished by restriction with SacII or BstEII. There was a SacII restriction site only in the 590-bp RT-PCR product representing the PAI III536-localized flu ortholog, which resulted in 250-bp and 340-bp restriction fragments upon SacII digestion. Conversely, a BstEII restriction site was uniquely present in the flu ortholog on PAI V536, and digestion of the 590-bp RT-PCR product resulted in 200-bp and 390-bp restriction fragments following restriction with BstEII. Consequently, the fraction of the PAI III536- and PAI V536-specific flu RT-PCR products in the pool of the 590-bp RT-PCR product could be assessed by selective digestion with either SacII or BstEII. For this purpose, the RT-PCR products obtained from wild-type strain 536 and its rfaH mutant were column purified (QIAquick spin columns). Aliquots were digested with 10 U of SacII or BstEII for 6 h before separation of the restriction fragments on agarose gels. The signal intensity of the undigested 590-bp RT-PCR product was then considered a measure of the fraction of either the PAI III536- and PAI V536-specific flu RT-PCR product in the common RT-PCR product pool. The primers used in RT-PCR experiments are described in the supplemental material.
| RESULTS |
|---|
|
|
|---|
|
These results demonstrated that the biofilm phenotype observed in strain 536 is not restricted to pathogenic E. coli strains and suggested that RfaH affects adhesion by modifying the expression of genes from the core genome shared by pathogenic and nonpathogenic strains of E. coli.
Comparison of transcriptional profiles of strains 536 and 536rfaH by using DNA arrays. Since the RfaH protein directly affects the expression of several bacterial cell envelope components, we investigated whether the increased-biofilm phenotype of the rfaH mutants could be due to changes in the physicochemical characteristics of the cell surface. The wild-type strains and isogenic rfaH mutants were compared with respect to surface charge and hydrophobicity. No major alterations in either surface charge or hydrophobicity due to rfaH inactivation could be consistently correlated with the different adhesive phenotypes of strains 536rfaH and MG1655rfaH (data not shown). These results, as well as our data showing that the rfaH mutation positively affects the initial adhesion step of biofilm formation, led to the hypothesis that increased adhesion to solid surfaces by the rfaH mutants depends on the production of specific adhesion factors prior to surface adhesion in planktonic cells. In order to identify RfaH-dependent factors that are responsible for the observed enhanced biofilm phenotype, the transcription profiles of strains 536 and 536rfaH were compared. In the absence of an existing UPEC strain 536-specific genome array, we used both an E. coli pathoarray, which allowed us to detect alterations in the levels of transcripts of the majority of the open reading frames (ORFs) present on PAI I536 to PAI V536 of strain 536, and an E. coli K-12-specific core genome array.
The analysis of the transcription profiles showed that expression of only a limited number of genes was significantly altered by more than twofold in the rfaH mutant compared to the wild type (Table 2).
|
Interestingly, transcriptome analysis using the E. coli "pathoarray" showed that the transcript levels of five genes localized on PAIs were significantly reduced in the rfaH mutant of strain 536 compared to the wild type by factors greater than 2. These ORFs include the known RfaH-dependent virulence determinant hly (59), which is located on PAI I536 and PAI II536, as well as ORF35 on PAI II536, which encodes a putative DNA methyltransferase. RfaH-dependent K15 capsule-encoding genes (kpsE, kpsF, and kpsS), located on PAI V536, were found to be repressed by the rfaH mutation by a factor of 1.6, as was another previously known RfaH-activated gene, chuA, encoding a hemin receptor. In addition, the transcript levels of two ORFs (ORF52III and ORF47V) were significantly increased in the rfaH mutant. These ORFs are localized on PAI III536 or PAI V536 and code for two similar but not identical Ag43 orthologs. Ag43 variants are usually encoded on variable mobile DNA regions, such as pathogenicity islands or plasmids, and a single strain of pathogenic E. coli may carry multiple copies of the same flu gene or different flu alleles (54, 74, 87). Recent sequence analysis indicated that UPEC strain 536 contains only a single copy of each of the agn43 orthologs ORF52III and ORF47V. This was confirmed by Southern hybridization of genomic DNA of strain 536 with an agn43-specific probe complementary to a conserved part of the passenger domain (see Fig. S2 in the supplemental material). Since the autotransporter protein antigen 43 encoded by these genes is involved in E. coli biofilm formation, its altered expression represented a likely explanation for the increased-biofilm phenotype in rfaH mutant strains.
Different roles for Ag43 in the increased-biofilm phenotype of the rfaH mutants of uropathogenic E. coli strain 536 and nonpathogenic K-12 strain MG1655. We tested whether Ag43 was involved in the increased-biofilm phenotype of the rfaH mutants. The genes encoding the two flu orthologs (both on PAIs) were deleted in uropathogenic wild-type strain 536 and an isogenic rfaH mutant. Strains carrying the different combination of mutations were tested for the capacity to form biofilms in microfermentors (Fig. 2). The data demonstrated that neither of the flu orthologs was necessary for the increased-biofilm phenotype of strain 536rfaH.
|
|
|
|
|
Consequently, we considered the possibility of an indirect role for RfaH through regulation of the expression of other regulatory genes that may repress flu expression. Such an indirect effect could be mediated by an RfaH-dependent modification of the switching frequency of flu transcription. We directly measured the effect of the rfaH mutation on MG1655 flu gene expression switching by using a plasmid-based lacZ fusion that has been shown to provide an accurate estimate of the chromosomal flu ON/OFF promoter switch (91). A colorimetric assay using X-Gal (5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside) agar plates was performed with the wild-type and rfaH strains. This assay, starting with a colony in either the ON or OFF state, showed that RfaH has no influence on the switching frequency of the flu promoter (data not shown). Additionally, RT-PCR was used to quantify the transcript levels of two known regulators of this switching frequency, oxyR and dam. The RT-PCR experiments were performed with cultures in the exponential and stationary growth phases, as well as with samples of biofilm material. As shown on our website (Fig. S3 in the supplemental material), rfaH inactivation affected neither dam nor oxyR transcript levels in the K-12 and UPEC strains. These results suggest that the role of RfaH in flu gene expression is not mediated either by the regulatory oxyR and dam genes or by a change in the flu ON/OFF promoter switch frequency and may involve another factor. Alternative hypotheses are discussed below.
rfaH mutation induces tight cell packing that is flu independent. To examine whether the absence of RfaH leads to structural differences in the biofilm formed by E. coli, we performed three independent scanning electron microscopy (SEM) analyses of various derivatives of UPEC strain 536 and K-12 strain MG1655.
In UPEC strain 536, mutation of the rfaH gene led to tight packing of the bacterial cells within the biofilm, which was not observed with wild-type bacteria. The rfaH mutation also decreased the amount of fibrillar structures, which most likely represented a condensed extracellular matrix due to fixation of biofilm samples and which seemed to connect the bacteria in biofilms formed by wild-type strain 536. Complementation of 536rfaH by a wild-type copy of rfaH restored both of these phenotypes (Fig. 6A). Mutation of the flu orthologs of strain 536 did not appear to modify the compact nature of cells of strain 536rfaH, thus confirming that the presence of the two Ag43-like proteins was dispensable for expression of the biofilm-related null rfaH phenotype.
|
Search for alternative mechanisms causing increased biofilm formation by the rfaH mutant of strain 536. As shown above, up-regulation of flu-like transcripts could not explain the increased biofilm formation ability of the 536rfaH mutant (Fig. 2). This phenotype could be explained by reduction of transcription of putative ORF35 of PAI II536, one of the genes found to be significantly repressed in the absence of RfaH (Table 2). Interestingly, ORF35 of PAI II536 contains a cis-acting upstream ops element. Since ORF35PAI II encodes a putative DNA methyltransferase, a different DNA methylation status due to reduced ORF35PAI II transcript levels in the rfaH mutant may affect the expression of some surface appendages, in analogy to the regulatory role of the Dam methylase in E. coli (31, 43). In order to test whether the reduction of ORF35PAI II transcription could be responsible for the rfaH-dependent biofilm phenotype, ORF35PAI II was deleted in strain 536. However, this mutation had no effect on the ability of strain 536 to form biofilms (data not shown).
Alternatively, it was recently found that capsule could block specific cell-cell or cell-surface interactions. Previous studies demonstrated that LPS and capsule expression are impaired in strain 536rfaH, and our macroarray analysis also indicated that the levels of expression of the phosphomannomutase cpsG gene and K15 capsule genes kpsE, kpsF, and kpsS are reduced in E. coli 536rfaH. Therefore, the reduced capsule and LPS expression caused by an rfaH mutation could allow shorter surface-associated structures to contribute to the initial adherence and/or biofilm formation (39, 65, 80, 83). In order to evaluate whether the lack of LPS or capsule could be involved in the RfaH-dependent biofilm phenotype, we inactivated in wild-type strain 536 the waaG, manB, and cpsG genes, which resulted in elimination of production of long-chain LPS and colanic acid. In addition, we also included a K15 capsule-negative mutant of strain 536 in the biofilm assays. Neither the colanic acid-negative mutant nor the K15 capsule-negative mutant exhibited an increased-biofilm phenotype, indicating that the reduction in expression of the cps and kps determinants could not explain the massive increased-biofilm phenotype of mutant strain 536rfaH (Fig. S4 in the supplemental material). Inactivation of manB, coding for a phosphomannomutase involved in LPS O-side chain biosynthesis, reduced the side chain length of the LPS but did not affect biofilm formation. Furthermore, mutation of waaG, coding for an LPS core glycosyltransferase that resulted in a truncated LPS core structure and a deep rough phenotype, completely abolished biofilm formation by strain 536 without affecting its growth rate in liquid culture (Fig. S4 in the supplemental material), suggesting that an intact LPS core is a major factor for adhesion to abiotic surfaces in E. coli strain 536.
LPS depletion in the rfaH mutant may lead to unmasking of surface adhesins in E. coli MG1655.
In order to investigate the possible unmasking of a short surface-associated adhesin in the biofilm phenotype observed for the E. coli K-12 rfaH mutant, we estimated the biofilm formation abilities of E. coli K-12 mutants impaired for production of colanic acid and/or semirough LPS, whose synthesis is dependent on RfaH in E. coli K-12. Whereas mutation of colanic acid did not affect biofilm formation by strain MG1655 in a microfermentor, a net increase in biofilm biomass was observed for the strains containing the LPS mutation rfa1 (
rfaGPSBI) (Fig. 7). This result suggested that LPS depletion in an rfaH mutant could unmask a short surface-associated adhesin. Based on its role in the biofilm phenotype of an E. coli K-12 rfaH mutant (Fig. 3), Ag43 was an obvious candidate for such a surface adhesin. We therefore introduced a flu mutation into strain MG1655rfa1. As shown in Fig. 7, the introduction of the flu mutation into strain MG1655rfa1 indeed reversed the hyper-biofilm phenotype caused by depletion of long-chain LPS. We also observed that loss of semirough LPS in wild-type strain MG1655 resulted in enhanced autoaggregation (data not shown), a phenotype previously observed upon introduction of the rfaH mutation. However, as in the case of the rfaH-dependent aggregation phenotype (Fig. S1 in the supplemental material), the increased autoaggregation was not dependent on Ag43 (data not shown).
|
| DISCUSSION |
|---|
|
|
|---|
RfaH indirectly regulates the expression of flu and flu orthologs in UPEC strain 536 and K-12 strain MG1655. To identify factors that are involved in the RfaH-dependent biofilm phenotype, the transcriptomes of the rfaH mutant and wild-type strain 536 were compared. Although the arrays used did not allow whole-genome transcriptional profiling, we nevertheless identified in both uropathogenic E. coli strain 536 and nonpathogenic E. coli K-12 strain MG1655 the flu genes as candidate genes involved in the increased-biofilm phenotype of the rfaH mutants.
In UPEC strain 536, the ORF52III transcript level decreased upon rfaH inactivation, whereas the ORF47V transcript level was markedly increased (Fig. 4B). Similarly, the ORF47III protein level was only slightly increased in the rfaH mutant, whereas the level of the ORF47V protein was increased greatly (Table 3). Owing to the absence of detectable ops elements in the flu upstream regions, it is likely that RfaH does not directly affect flu expression via the ops element and interaction with the RNA polymerase (3, 4). Phase variation may regulate expression of both flu orthologs, although in opposite ways. Phase-variable expression of Ag43 is due to the concerted action of the Dam methylase and the cellular redox sensor OxyR and has been extensively studied in E. coli K-12 (37, 42, 82, 91-93). Although the upstream regions of the two E. coli 536 flu orthologs are not identical, three Dam DNA methylation sites, as well as an OxyR motif, are present upstream of ORF52III and ORF47V. The absence of variation of the Ag43 switch frequency in an rfaH mutant, however, excludes an indirect effect of RfaH on flu expression via modification of dam or oxyR gene expression.
Other possible indirect repression of flu by RfaH may occur via variation of the redox state of OxyR toward its reduced form. The expression of fimbrial organelles containing disulfide bonds could affect the redox status of OxyR and thus Ag43 expression (81, 82). However, since recent indications have shown that phase variation of Ag43 is independent of the oxidation status of OxyR (92) and that the levels of type 1 fimbria expression, as well as S- and P- fimbria expression, are not different in strains 536 and 536rfaH (65), another unknown regulatory mechanism is likely to be involved in the RfaH-mediated flu expression. Hypotheses such as an indirect effect of RfaH on the expression or stability of flu mRNAs or Ag43 proteins have to be considered.
Alternative Ag43-independent mechanisms are involved in the increased biofilm formation by the rfaH mutant of UPEC strain 536.
Ag43 affects colony morphology and mediates autoaggregation, thus contributing to cell-to-cell adhesion and biofilm formation (18, 40, 41, 52, 54). Nevertheless, the flu orthologs may not play a central role in the RfaH-dependent biofilm phenotype of strain 536. It has been found previously that Ag43 enhances biofilm formation primarily by providing efficient cell-to-cell adhesion, which in turn stimulates formation of premature biofilms (53). However, Ag43 has also been shown to be dispensable for biofilm formation as it can be replaced by alternative factors (72). The observation that the difference in biofilm formation between wild-type strain 536 and its rfaH mutant becomes smaller after prolonged incubation (data not shown) also corroborates the findings of Klemm and coworkers (53) that Ag43 expression particularly promotes formation of premature biofilms and that, at later stages, other factors come into play. This factor(s) is probably also responsible for the enhanced cell-cell interactions within the 536rfaH biofilm, as observed by SEM analysis. The larger genome of strain 536 (
4.94 Mb) compared to that of strain MG1655 (4.63 Mb) underlines the possibility that additional gene products of strain 536 which are absent in strain MG1655 may promote biofilm formation. Other candidate RfaH-regulated factors in strain 536 whose absence could increase biofilm formation, either through modification of the ON-OFF phase switching frequency of surface appendages (ORF35 of PAI II536) or through unmasking of other shorter surface-associated structures (colanic acid, K15 capsule, and long-chain LPS), were tested. None of the corresponding mutations enhanced the capacity of strain 536 to form biofilms. In contrast, the further truncation of the LPS core structure in E. coli strain 536waaG compared to strain 536rfaH severely impaired biofilm formation (see Fig. S4 in the supplemental material at http://www.uni-wuerzburg.de/infektionsbiologie/imistart.htm and at http://www.pasteur.fr/recherche/unites/Ggb/supmat.html). In previous reports workers described LPS as a molecule that is important for adhesion of different pathogenic bacteria, such as Pseudomonas fluorescens, Serratia marcescens, and Klebsiella pneumoniae (23, 45), to abiotic surfaces. The absence of biofilm formation by strain 536waaG is consistent with these reports and suggests that LPS, especially the LPS core, is critical for adhesion of E. coli strain 536 to abiotic surfaces (Fig. S4). Whereas the different extracellular polysaccharides are not responsible for the increased biofilm formation by strain 536rfaH, we cannot rule out the possibility that a surface-associated adhesin is effectively unmasked in 536rfaH by depletion of an unidentified RfaH-regulated E. coli 536 surface component, thus contributing to the increased-biofilm phenotype.
In E. coli MG1655 the rfaH-dependent biofilm phenotype may involve unmasking of Ag43. In contrast to the situation observed in E. coli 536, the increased Ag43 level is positively correlated with an increased-biofilm phenotype in E. coli K-12 strain MG1655rfaH. Accordingly, the enhanced three-dimensional growth of the biofilm observed in the rfaH mutants could be due to increased cell-cell interactions via Ag43. Loss of semirough LPS in the rfa1 mutant, similar to the loss caused by an rfaH mutation, led to an increased-biofilm phenotype. As in strain MG1655rfaH, this phenotype was reversed by the flu mutation in strain MG1655rfa1. Therefore, as shown for adhesin shielding by expression of the capsule (39, 80), we propose that in the presence of RfaH, the LPS core of K-12 strain MG1655 could physically shield Ag43, preventing its exposure to the cell surface. Modification of the LPS structure may well be used by bacteria to modulate their capacities to form biofilms. Interestingly, in Shigella flexneri, a mechanism that enhances type III secretion, and therefore modulates virulence, has recently been described, and it involves modification of the LPS structure, leading to unmasking of the needle-like secretion structure (95).
Hence, in E. coli K-12, the rfaH mutation could lead to strong adhesion and biofilm formation by two distinct mechanisms, through an increase in the quantity of Ag43 and possibly by unmasking due to LPS core depletion. This hypothesis may account for the macroscopic difference observed between the smooth fragile oxyR mutant biofilms and the granular and more robust biofilms formed by the rfaH mutant (data not shown). The surface exposure and unmasking of a large amount of Ag43 produced in the rfaH oxyR background may explain the additive effect on biofilm formation observed when these two mutations are combined. The different roles of Ag43 proteins in the rfaH biofilm phenotypes of K-12 and UPEC strains suggest that the rfaH mutants of strains produce more biofilm for different reasons. Despite the considerable genetic differences between the two E. coli strains, RfaH affects biofilm formation by different but convergent intermediate pathways in the strains.
rfaH-dependent biofilm phenotype of E. coli K-12 strain MG1655 may also require surface adhesins other than Ag43. Several lines of evidence presented in this paper support the hypothesis that factors other than Ag43 might also be involved in increased biofilm formation by E. coli strain MG1655. The flu deletion in strain MG1655rfaH did not modify the spacing between cells observed in this strain (Fig. 6B), and Ag43-independent cellular autoaggregation was also observed in strains MG1655rfaH flu and MG1655rfa1 flu (Fig. S1 in the supplemental material; data not shown). This suggests that in strain MG1655rfaH another factor(s) is also induced or, alternatively, unmasked by the RfaH depletion. We recently identified new adhesins in E. coli K-12 by virtue of their sequence homology to Ag43 and the increased abiotic surface adhesion caused by their overexpression (77). Nevertheless, mutation of any of the genes encoding these adhesins, either the type I-encoding gene fimA or the curli-encoding gene csgA, was not able to reverse the increased autoaggregation of the MG1655 rfaH mutant (data not shown).
Relationships between RfaH-mediated virulence and biofilm formation. There is considerable knowledge regarding virulence-associated factors of E. coli. However, the relationship between pathogenesis and biofilm formation is still poorly understood. In this study we demonstrated that RfaH, besides positively affecting virulence gene expression, plays a role in repressing E. coli biofilm formation.
Since expression of several E. coli virulence-associated genes depends on RfaH, the increased-biofilm phenotype of the nonvirulent rfaH mutant of strain 536 indicates that RfaH-dependent biofilm formation and virulence gene expression (63, 65) are mutually exclusive processes and that biofilm formation may not be regarded as a virulence trait per se.
Recently, the two-component sensor kinase/response regulator hybrid protein RetS of P. aeruginosa has been shown to inversely coordinate the control of genes required for biofilm formation and acute infection in cystic fibrosis patients (35). Whereas the capacity to form a biofilm may be required for other aspects of P. aeruginosa pathogenesis, such as chronic persistence, incompatibility between colonization or infection of the plant vascular system and biofilm formation has been demonstrated in the case of the plant pathogen Xanthomonas campestris. This bacterium alternates between the biofilm and noninfective lifestyle and the fully infective and free-swimming form through cell-cell-signaled dispersal of the biofilm (30). Expression of a type III secretion system of P. aeruginosa and expression of an adenylate cyclase toxin of Bordetella bronchiseptica, both of which are required for acute infection, were shown to inhibit biofilm formation (44, 55).
Consistently, recent data indicate that biofilms of uropathogenic E. coli have to be formed at the right place under appropriate conditions and that this may also promote virulence under certain growth conditions (2, 51). Our findings suggest that derepression of biofilm formation could therefore contribute to the absence of virulence of strain 536rfaH. It has been demonstrated that in Salmonella, rfaH expression itself is affected by the growth phase and the sigma factors RpoN and RpoS (8, 27), which are also known to regulate several virulence determinants in different microorganisms. Hence, modulation of biofilm formation via RfaH could be a mechanism by which bacteria fine-tune their virulence properties, especially in response to environmental signals. This suggests that there are complex regulatory circuits for virulence traits and biofilm formation that have to be analyzed in the future in order to complete our knowledge of factors involved in chronic and recurring UTI.
| ACKNOWLEDGMENTS |
|---|
The Würzburg group was supported by the DFG (SFB479, TP A1), the "Fonds der Chemischen Industrie," and the "Bayerische Forschungsstiftung." J.-M.G. and C.B. were supported by the Institut Pasteur, as well as by CNRS and Fondation BNP Paribas grants.
| FOOTNOTES |
|---|
C.B. and K.M. contributed equally to this work. ![]()
| REFERENCES |
|---|
|
|
|---|